We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+6.71%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
AUM
$3.11B
AUM Growth
+$140M
Cap. Flow
-$14.3M
Cap. Flow %
-0.46%
Top 10 Hldgs %
31.89%
Holding
3,618
New
197
Increased
1,211
Reduced
1,200
Closed
258

Sector Composition

Rank Sector Weight
1 Technology 15.43%
2 Healthcare 8.51%
3 Financials 6.64%
4 Consumer Discretionary 4.61%
5 Communication Services 4.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OMGA
2801
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$1.66K ﹤0.01%
296
PRTK
2802
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$1.66K ﹤0.01%
+750
New +$1.55K
XIN
2803
DELISTED
Xinyuan Real Estate
XIN
$1.66K ﹤0.01%
+500
New +$1.78K
FATE icon
2804
Fate Therapeutics
FATE
$326M
$1.64K ﹤0.01%
345
+191
+124% +$1.05K
CEQP
2805
DELISTED
Crestwood Equity Partners LP
CEQP
$1.64K ﹤0.01%
62
CASS icon
2806
Cass Information Systems
CASS
$743M
$1.63K ﹤0.01%
42
-2
-5% -$79
RDWR icon
2807
Radware
RDWR
$1.19B
$1.63K ﹤0.01%
84
NKLA
2808
DELISTED
Nikola Corporation Common Stock
NKLA
$1.63K ﹤0.01%
39
-28
-42% -$772
ITEQ icon
2809
Amplify BlueStar Israel Technology ETF
ITEQ
$119M
$1.62K ﹤0.01%
+35
New +$1.59K
MRVI icon
2810
Maravai LifeSciences
MRVI
$919M
$1.62K ﹤0.01%
130
-907
-87% -$12.2K
ABEO icon
2811
Abeona Therapeutics
ABEO
$413M
$1.61K ﹤0.01%
400
AORT icon
2812
Artivion
AORT
$1.32B
$1.6K ﹤0.01%
93
SUPN icon
2813
Supernus Pharmaceuticals
SUPN
$2.77B
$1.59K ﹤0.01%
53
AGEN
2814
Agenus
AGEN
$290M
$1.59K ﹤0.01%
50
-8
-14% -$256
ADVM
2815
DELISTED
Adverum Biotechnologies
ADVM
$1.59K ﹤0.01%
100
MLPA icon
2816
Global X MLP ETF
MLPA
$2.28B
$1.59K ﹤0.01%
37
SYBT icon
2817
Stock Yards Bancorp
SYBT
$2.6B
$1.59K ﹤0.01%
35
-52
-60% -$2.44K
HASI icon
2818
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.2B
$1.57K ﹤0.01%
63
-82
-57% -$2.15K
FFBC icon
2819
First Financial Bancorp
FFBC
$3.53B
$1.57K ﹤0.01%
77
-26
-25% -$529
SILJ icon
2820
Amplify Junior Silver Miners ETF
SILJ
$3.85B
$1.56K ﹤0.01%
166
MOR
2821
DELISTED
MorphoSys AG American Depositary Shares
MOR
$1.55K ﹤0.01%
+208
New +$1.27K
GTN icon
2822
Gray Television
GTN
$552M
$1.55K ﹤0.01%
197
+96
+95% +$738
TCMD icon
2823
Tactile Systems Technology
TCMD
$665M
$1.55K ﹤0.01%
62
AFCG
2824
AFC Gamma
AFCG
$63.4M
$1.54K ﹤0.01%
181
CPE
2825
DELISTED
Callon Petroleum Company
CPE
$1.54K ﹤0.01%
44
+30
+214% +$1K

Similar funds

Parallel Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Parallel Advisors held 3,618 positions worth $3.11B, up 4.7% from $2.97B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Parallel Advisors's Q2 2023 filing shows 197 new, 1,211 increased, 1,200 reduced and 258 closed positions. Its largest new stake was JPMorgan Nasdaq Equity Premium Income ETF: 11,017 shares worth $533K. The largest sale was Invesco S&P 500 Equal Weight ETF, an estimated $39.5M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

  • Parallel Advisors's largest Q2 2023 buy was JPMorgan Nasdaq Equity Premium Income ETF: 11,017 shares worth $533K.
  • Parallel Advisors added most to iShares MSCI USA Quality Factor ETF in Q2 2023, an estimated $72.4M increase.
  • Parallel Advisors's biggest Q2 2023 reduction was Invesco S&P 500 Equal Weight ETF, cutting an estimated $39.5M.
  • Parallel Advisors fully exited Cvent Holding Corp. Common Stock in Q2 2023, selling an estimated $1.62M.
  • Parallel Advisors's ten largest holdings make up 32% of its $3.11B portfolio in Q2 2023.
  • Parallel Advisors opened 197 new positions and closed 258 in Q2 2023.
  • Parallel Advisors's portfolio value rose 4.7% quarter-over-quarter to $3.11B.

Based on Parallel Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.